176 related articles for article (PubMed ID: 4729321)
21. Chemotherapy of bronchogenic carcinomas by a combination of cyclophosphamide, methotrexate, vincristin and bleomycin.
Schaerer R; Sotto JJ; Wiget U; Perdrix A; Bensa JC; Ribaud P
Eur J Cancer (1965); 1977; 13(4-5):425-8. PubMed ID: 68881
[No Abstract] [Full Text] [Related]
22. [After care in bronchial carcinoma. Results of postoperative polychemotherapy].
Karrer K; Pridun N; Denck H
Fortschr Med; 1976 Mar; 94(7):379-85. PubMed ID: 184021
[No Abstract] [Full Text] [Related]
23. Combined radiotherapy and chemotherapy with cyclophosphamide, adriamycin, methotrexate, procarbazine (CAMP) in 64 consecutive patients with epidermoid bronchogenic carcinoma, limited disease: a prospective study.
Trovò MG; Tirelli U; De Paoli A; Franchin G; Roncadin M; Magri M; Galligioni E; Veronesi A; Tumolo S; Carbone A; Grigoletto E
Int J Radiat Oncol Biol Phys; 1982 Jun; 8(6):1051-4. PubMed ID: 7107434
[TBL] [Abstract][Full Text] [Related]
24. Cytoxan therapy in the treatment of carcinoma of the lung. (Report of a five-year survival).
Castro L
W V Med J; 1974 Jun; 70(6):131-5. PubMed ID: 4524737
[No Abstract] [Full Text] [Related]
25. Proceedings: Small cell carcinoma of the lung: staging, paraneoplastic syndromes, treatment, and survival.
Eagan RT; Maurer LH; Forcier RJ; Tulloh M
Cancer; 1974 Feb; 33(2):527-32. PubMed ID: 4812770
[No Abstract] [Full Text] [Related]
26. Recent therapeutic developments in lung cancer.
Hansen HH; Selawry OS
Med Ann Dist Columbia; 1971 Sep; 40(9):580-2. PubMed ID: 4939062
[No Abstract] [Full Text] [Related]
27. Chemotherapy for small cell bronchogenic carcinoma: CCNU and doxorubicin compared to CCNU, doxorubicin, vincristine, and procarbazine.
Vogelzang NJ; Trowbridge RC; Frenning DH; Theologides A; Kennedy BJ; Kelly DR; Ewing SL; Vosika GJ
Cancer Treat Rep; 1980; 64(8-9):997-1000. PubMed ID: 6256076
[TBL] [Abstract][Full Text] [Related]
28. Long-term effects of intravenous hyperalimentation administered during intensive chemotherapy for small cell bronchogenic carcinoma.
Valdivieso M; Frankmann C; Murphy WK; Benjamin RS; Barkley HT; McMurtrey MJ; Jeffries DG; Welch SR; Bodey GP
Cancer; 1987 Jan; 59(2):362-9. PubMed ID: 3026605
[TBL] [Abstract][Full Text] [Related]
29. Combination chemotherapy with vincristine, adriamycin, and procarbazine in previously treated patients with small cell carcinoma.
Cohen MH; Broder LE; Fossieck BE; Bull M; Ihde DC; Minna JD
Cancer Treat Rep; 1977; 61(3):485-7. PubMed ID: 194693
[No Abstract] [Full Text] [Related]
30. Chemotherapy for lung cancer at the Institute of Experimental and Clinical Oncology, Academy of Medical Sciences, USSR.
Perevodchikova NI; Bychkov MB
Cancer Chemother Rep 3; 1973 Mar; 4(2):251-5. PubMed ID: 4199645
[No Abstract] [Full Text] [Related]
31. [Cancer chemotherapy of inoperable bronchial carcinomas (author's transl)].
Rieche K
Z Erkr Atmungsorgane; 1975 Feb; 142(2):140-8. PubMed ID: 179223
[TBL] [Abstract][Full Text] [Related]
32. Chemotherapy for lung cancer.
Golbey RB
Postgrad Med; 1978 Feb; 63(2):137-41. PubMed ID: 75540
[TBL] [Abstract][Full Text] [Related]
33. A combination of cyclophosphamide, methotrexate, vincristine and VP 16-213 (NSC 141 540) in the treatment of bronchogenic carcinoma.
Cavalli F; Hasler E; Ryssel HJ; Sonntag RW; Brunner KW
Tumori; 1977; 63(2):169-73. PubMed ID: 898287
[TBL] [Abstract][Full Text] [Related]
34. Lessons from a time capsule: evolution, not revolution, in therapy for advanced non-small-cell lung cancer.
Green MR
J Clin Oncol; 2008 Jul; 26(19):3112-3. PubMed ID: 18591551
[No Abstract] [Full Text] [Related]
35. Methotrexate in the chemotherapy of lung cancer.
Smyth JF; Ford HT
Cancer Treat Rep; 1981; 65 Suppl 1():161-3. PubMed ID: 6275986
[TBL] [Abstract][Full Text] [Related]
36. [Polychemotherapeutic treatment of pulmonary neoplasms].
Dorigoni A; Peris GC; Scarponi F; Alcozer G
G Pneumol; 1970 Jun; 14(3):164-92. PubMed ID: 5526216
[No Abstract] [Full Text] [Related]
37. Radiotherapy for bronchogenic carcinoma: actual difficulties and plans for the future.
Dana M
Cancer Chemother Rep 3; 1973 Mar; 4(2):153-5. PubMed ID: 4734076
[No Abstract] [Full Text] [Related]
38. Small cell undifferentiated bronchogenic carcinoma: current status with emphasis upon the role of chemotherapy.
Johnson PS; Foley JF; Kessinger A; Lemon HM
J Surg Oncol; 1978; 10(6):549-57. PubMed ID: 215847
[TBL] [Abstract][Full Text] [Related]
39. [Combination chemotherapy in patients with disseminated bronchogenic carcinoma (author's transl)].
Gropp C; Havemann K; Gassel WD; Hess F; Prignitz R; Schmidt M; Sodomann CP
Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1977 Dec; 90(3):301-6. PubMed ID: 146331
[TBL] [Abstract][Full Text] [Related]
40. [Trials of synchronized attack drug therapy in bronchogenic carcinoma].
Seccia A; Scafuri L; Scognamillo A; Cocco G
G Ital Chemioter; 1975; 22(1-2):63-6. PubMed ID: 1235355
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
